Literature DB >> 11496945

Fractal volume of drug distribution: it scales proportionally to body mass.

V Karalis1, L Claret, A Iliadis, P Macheras.   

Abstract

PURPOSE: To develop the physiologically sound concept of fractal volume of drug distribution, vf, and evaluate its utility and applicability in interspecies pharmacokinetic scaling.
METHODS: Estimates for vf of various drugs in different species were obtained from the relationship: vf = (v - Vpl)(Vap - Vpl)/V + Vpl where v is the total volume of the species (equivalent to its total mass assuming a uniform density Ig/mL), Vpl is the plasma volume of the species and Vap is the conventional volume of drug distribution. This equation was also used to calculate the fractal analogs of various volume terms of drug distribution (the volume of central compartment, Vc, the steady state volume of distribution, Vss, and the volume of distribution following pseudodistribution equilibrium, Vz). The calculated fractal volumes of drug distribution were correlated with body mass of different mammalian species and allometric exponents and coefficients were determined.
RESULTS: The calculated values of vf for selected drugs in humans provided meaningful and physiologically sound estimates for the distribution of drugs in the human body. For all fractal volume terms utilized, the allometric exponents were found to be either one or close to unity. The estimates of the allometric coefficients were found to be in the interval (0,1). These decimal values correspond to a fixed fraction of the fractal volume term relative to body mass in each one of the species.
CONCLUSIONS: Fractal volumes of drug distribution scale proportionally to mass. This confirms the theoretically expected relationship between volume and mass in mammalian species.

Entities:  

Mesh:

Year:  2001        PMID: 11496945     DOI: 10.1023/a:1010965001162

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

1.  Disposition of the selective alpha1A-adrenoceptor antagonist tamsulosin in humans: comparison with data from interspecies scaling.

Authors:  E J van Hoogdalem; Y Soeishi; H Matsushima; S Higuchi
Journal:  J Pharm Sci       Date:  1997-10       Impact factor: 3.534

2.  Interspecies scaling: predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance.

Authors:  I Mahmood; J D Balian
Journal:  J Pharm Sci       Date:  1996-04       Impact factor: 3.534

3.  Pharmacokinetics of procaterol in the rat, rabbit and beagle dog.

Authors:  M Ishigami; K Saburomaru; K Niino; M Kido; S Morita; G Miyamoto; H Kohri
Journal:  Arzneimittelforschung       Date:  1979

4.  Comparative pharmacokinetics and interspecies scaling of amphotericin B in several mammalian species.

Authors:  A Hutchaleelaha; H H Chow; M Mayersohn
Journal:  J Pharm Pharmacol       Date:  1997-02       Impact factor: 3.765

5.  Prediction of the human pharmacokinetics of troglitazone, a new and extensively metabolized antidiabetic agent, after oral administration, with an animal scale-up approach.

Authors:  T Izumi; S Enomoto; K Hosiyama; K Sasahara; A Shibukawa; T Nakagawa; Y Sugiyama
Journal:  J Pharmacol Exp Ther       Date:  1996-06       Impact factor: 4.030

6.  Disposition of remoxipride in different species. Species differences in metabolism.

Authors:  M Widman; L B Nilsson; B Bryske; J Lundström
Journal:  Arzneimittelforschung       Date:  1993-03

7.  Interspecies correlation of the pharmacokinetics of erythromycin, oleandomycin, and tylosin.

Authors:  G S Duthu
Journal:  J Pharm Sci       Date:  1985-09       Impact factor: 3.534

8.  Phencyclidine pharmacokinetic scaling among species.

Authors:  S M Owens; W C Hardwick; D Blackall
Journal:  J Pharmacol Exp Ther       Date:  1987-07       Impact factor: 4.030

9.  Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.

Authors:  H M Siefert; D Maruhn; W Maul; D Förster; W Ritter
Journal:  Arzneimittelforschung       Date:  1986-10

10.  Pharmacokinetic and toxicity scaling of the antitumor agents amsacrine and CI-921, a new analogue, in mice, rats, rabbits, dogs, and humans.

Authors:  J W Paxton; S N Kim; L R Whitfield
Journal:  Cancer Res       Date:  1990-05-01       Impact factor: 12.701

View more
  3 in total

1.  Multivariate statistics of disposition pharmacokinetic parameters for structurally unrelated drugs used in therapeutics.

Authors:  Vangelis Karalis; Anna Tsantili-Kakoulidou; Panos Macheras
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

Review 2.  Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.

Authors:  K Sandy Pang; Michael Weiss; Panos Macheras
Journal:  AAPS J       Date:  2007-06-29       Impact factor: 4.009

3.  Scaling of myocardial mass to flow and morphometry of coronary arteries.

Authors:  Jenny Susana Choy; Ghassan S Kassab
Journal:  J Appl Physiol (1985)       Date:  2008-03-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.